Consistent with the observed elevation in MRCK expression in cutaneous squamous cell carcinoma (SCC) relative to normal human skin, the topical application of BDP9066 reduced tumour growth, but not tumour initiation, in a chemically induced mouse model of skin cancer [32]. The gene discussed is CDC42BPA; the disease is neoplasm.